During the past decade, Nebraska Health System conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nebraska Health System" #1 sponsor was "Radiation Therapy Oncology Group" with 27 trials, followed by "University of Nebraska" with 7 trials sponsored, "Medtronic" with 3 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored and "Center for International Blood and Marrow Transplant Research" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nebraska Health System" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Nebraska Health System" are "Head and Neck Cancer" (7 trials), "Lung Cancer" (4 trials), "Metastatic Cancer" (4 trials), "Prostate Cancer" (4 trials) and "Radiation Toxicity" (4 trials). Many other conditions were trialed in "Nebraska Health System" in a lesser frequency.

Most popular intervention types in "Nebraska Health System" are "Drug" (25 trials), "Radiation" (24 trials), "Procedure" (14 trials), "Biological" (6 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (25 trials), "conventional surgery" (7 trials), "cisplatin" (6 trials), "filgrastim" (4 trials) and "paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Nebraska Health System" are 37 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Nebraska Health System". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Nebraska Health System, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nebraska Health System, 6 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".